MUROMACHI CHEMICALS INC. Logo

MUROMACHI CHEMICALS INC.

A diversified manufacturer of pharmaceuticals, chemical systems, health foods & functional materials.

4885 | T

Overview

Corporate Details

ISIN(s):
JP3914800002
LEI:
Country:
Japan
Address:
大牟田市新勝立町一丁目38番5
Sector:
Manufacturing
Industry:
Manufacture of pharmaceuticals, medicinal chemical and botanical products

Description

Muromachi Chemicals Inc. is a diversified manufacturer operating across four core business segments. The Pharmaceutical division produces and sells medical products and active pharmaceutical ingredients (APIs). The Chemical business specializes in high-performance, customized liquid treatment systems for various applications, including environmental solutions. The Consumer Healthcare division manufactures and markets health foods. Additionally, the Functional Materials segment supports customer development with a broad range of standard and custom-made products for diverse markets. Founded in 1917, the company leverages its long-standing expertise to develop and provide innovative solutions that contribute to health and society.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2025-08-26 03:41
Registration Form
確認書
Japanese 8.7 KB
2025-08-26 03:40
Registration Form
有価証券報告書-第79期(2024/06/01-2025/05/31)
Japanese 1020.4 KB
2025-01-14 08:01
Report Publication Announcement
確認書
Japanese 8.7 KB
2025-01-14 08:00
Interim Report
半期報告書-第79期(2024/06/01-2025/05/31)
Japanese 214.1 KB
2024-09-04 03:00
Post-Annual General Meeting Information
臨時報告書
Japanese 27.6 KB
2024-08-28 08:34
Governance Information
内部統制報告書-第78期(2023/06/01-2024/05/31)
Japanese 22.8 KB
2024-08-28 08:32
Registration Form
有価証券報告書-第78期(2023/06/01-2024/05/31)
Japanese 986.7 KB
2024-08-28 08:32
Registration Form
確認書
Japanese 8.7 KB
2024-04-12 09:01
Report Publication Announcement
確認書
Japanese 8.7 KB
2024-04-12 09:01
Quarterly Report
四半期報告書-第78期第3四半期(2023/12/01-2024/02/29)
Japanese 178.7 KB
2024-01-12 08:02
Quarterly Report
四半期報告書-第78期第2四半期(2023/09/01-2023/11/30)
Japanese 213.9 KB
2024-01-12 08:02
Report Publication Announcement
確認書
Japanese 8.7 KB
2023-10-13 09:02
Registration Form
確認書
Japanese 8.7 KB
2023-10-13 09:01
Quarterly Report
四半期報告書-第78期第1四半期(2023/06/01-2023/08/31)
Japanese 182.3 KB
2023-08-29 03:35
Post-Annual General Meeting Information
臨時報告書
Japanese 24.0 KB

Automate Your Workflow. Get a real-time feed of all MUROMACHI CHEMICALS INC. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for MUROMACHI CHEMICALS INC.

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for MUROMACHI CHEMICALS INC. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Prestige Consumer Healthcare Inc. Logo
Develops and markets leading over-the-counter brands for personal healthcare and wellness.
United States of America
PBH
Processa Pharmaceuticals, Inc. Logo
Develops next-gen chemo and therapies for chronic and life-threatening diseases.
United States of America
PCSA
Develops protein-based immunotherapies for metabolic diseases, immune disorders, and cancer.
South Korea
296160
PROKIDNEY CORP. Logo
Develops cellular therapies to preserve kidney function for patients with advanced Chronic Kidney Disease.
United States of America
PROK
ProMIS Neurosciences Inc. Logo
Developing selective antibody therapies targeting toxic proteins in neurodegenerative diseases.
United States of America
PMN
Propanc Biopharma, Inc. Logo
Developing proenzyme therapies to prevent solid tumor recurrence and metastasis.
United States of America
PPCB
ProQR Therapeutics N.V. Logo
Biotech developing RNA-editing therapies for genetic disorders using the body's own enzymes.
United States of America
PRQR
Protagenic Therapeutics, Inc.\new Logo
Developing novel peptide drugs to treat stress-related neuropsychiatric & CNS disorders.
United States of America
PTIX
Protagonist Therapeutics, Inc Logo
Develops peptide therapeutics for blood disorders and inflammatory or immunomodulatory diseases.
United States of America
PTGX
Protalix BioTherapeutics, Inc. Logo
Develops plant-cell-based protein therapies for rare diseases like Gaucher and Fabry.
United States of America
PLX

Talk to a Data Expert

Have a question? We'll get back to you promptly.